Topics :: medicine

1 thru 10 of 85 Stories
FDA Advisers Endorse Gene Therapy to Treat Form of Blindness

FDA Advisers Endorse Gene Therapy to Treat Form of Blindness

By Matthew Perrone | Oct 14
A potentially groundbreaking treatment for a rare form of blindness moved one step closer to U.S. approval Thursday, as federal health advisers endorsed the experimental gene therapy.

Seeing Hope: FDA Panel Considers Gene Therapy for Blindness

Seeing Hope: FDA Panel Considers Gene Therapy for Blindness

By Marilynn Marchione | Oct 12
On Thursday, U.S. Food and Drug Administration advisers will consider whether to recommend approval of a gene therapy that improved vision for these three youths and some others with hereditary blindness.

The Big Question: Will Cancer Immune Therapy Work for Me?

The Big Question: Will Cancer Immune Therapy Work for Me?

By Marilynn Marchione | Sep 23
People with the most messed-up genes often are the ones who do best on cancer treatments that enlist the immune system.

Testing Probe to Help Cancer Surgeons Know They Got It All

Testing Probe to Help Cancer Surgeons Know They Got It All

By Lauran Neergaard | Sep 13
Patients emerging from cancer surgery want to know, "Did you get it all?" Now scientists are developing a pen-like probe to help surgeons better tell when it's safe to stop cutting or if stray tumor cells still lurk.

U.S. Clears Breakthrough Gene Therapy for Childhood Leukemia

U.S. Clears Breakthrough Gene Therapy for Childhood Leukemia

By Lauren Neergaard | Sep 2
Opening a new era in cancer care, U.S. health officials have approved a breakthrough treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia.

FDA OKs Pfizer Drug for Rare, Fast-Killing Type of Leukemia

FDA OKs Pfizer Drug for Rare, Fast-Killing Type of Leukemia

By Linda A. Johnson | Aug 20
The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed.

First Safe Repair of Disease-Causing Gene in Human Embryos

First Safe Repair of Disease-Causing Gene in Human Embryos

By Lauran Neergaard | Aug 4
In a first, researchers safely repaired a disease-causing gene in human embryos, targeting a heart defect best known for killing young athletes - a big step toward one day preventing a list of inherited diseases.

Brain Scans May Change Care for Some People with Memory Loss

Brain Scans May Change Care for Some People with Memory Loss

By Lauran Neergaard | Jul 21
Not everybody needs one but new research suggests that for a surprising number of patients whose memory problems are hard to pin down, PET scans may lead to changes in treatment.

FDA Approves First New Drug in 20 Years for Sickle Cell

FDA Approves First New Drug in 20 Years for Sickle Cell

Jul 10
The U.S. Food and Drug Administration has approved the first drug in nearly 20 years for sickle cell, an inherited disease in which abnormally shaped red blood cells can't properly carry oxygen throughout the body.

New Frontier in Cancer Care: Turning Blood into Living Drugs

By Lauran Neergaard | Jun 14
Immune therapy is the hottest trend in cancer care and this is its next frontier - creating "living drugs" that grow inside the body into an army that seeks and destroys tumors.

1 thru 10 of 85 Stories